Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2011-07-19
2011-07-19
Lucas, Zachariah (Department: 1648)
Chemistry: molecular biology and microbiology
Vector, per se
C435S005000, C424S199100, C424S204100, C424S207100
Reexamination Certificate
active
07981671
ABSTRACT:
The invention concerns a recombinant vector characterized in that it comprises a polynucleotide comprising a central initiation cis-active region (cPPT) and a termination cis-active region (CTS) of retroviral or retroviral-like origin, further comprising a predetermined nucleotide sequence (transgene or nucleotide sequence of interest) and retrotranscription regulating, expressing and packaging signals of retroviral or retroviral-like origin.
REFERENCES:
patent: 6682907 (2004-01-01), Charneau et al.
patent: 2004/0081636 (2004-04-01), Charneau et al.
patent: 0 611 822 (1994-08-01), None
patent: WO 97/12622 (1997-04-01), None
patent: WO 9712622 (1997-04-01), None
patent: WO 97/32983 (1997-09-01), None
patent: WO 98/39463 (1998-09-01), None
patent: WO 98/46083 (1998-10-01), None
patent: WO 00/31280 (2000-06-01), None
Charneau et al. A Second Origin of DNA Plus-Strand Synthesis Is Required for Optimal Human Immunodeficiency Virus Replication. Journal of Virology 1992, vol. 66, No. 5, p. 2814-2820.
Parolin, C., Analysis in Human Immunodeficiency Virus Type 1 Vectors of cis-Acting Sequences That Affect Gene Transfer into Human Lymphocytes. Journal of Virology Jun. 1994, vol. 68, No. 6, p. 3888-3895.
Zufferey et al., Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo; Nature Biotechnology, vol. 15, (1997) 871-875.
Charneau et al, HIV-1 Reverse Transcription, A termination step at the center of the genome; J. Mol. Biol. (1994) 241, 651-662.
Charneau et al., A single-stranded gap in human immunodeficiency virus unintegrated linear DNA defined by a central the polypurine tract; J. Virol. (1991) 65, 2415-2421.
Charneau et al., A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication; J. Virol. (1992) 66, 2814-2820.
Erlwein et al., Sequences in pol are required for transfer of human foamy virus-based vectors; J. Virol. (1998) 72, 5510-5516.
Naldini et al, Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector; Proc. Natl. Acad. Sci. USA, (1996) vol. 93, 11382-11388.
Naldini et al, In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector; Science, vol. 272, (1996) 263-267.
Poznansky et al., Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector; J. Virol. (1991) 65, 532-536.
Stetor et al., Characterization of (+) strand initiation and termination sequences located at the center of the equine infectious anemia virus genome; Biochem. (1999) vol. 38, 3656-3667.
Kim et al.; Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: Evidence for differential gene expression; J. Virol. (1989) 63, 3708-3713.
Goldman et al.; Lentiviral vectors for gene therapy of cystic fibrosis; Human Gene Therapy (1997) 8, 2261-2268.
European Patent Office, Search reports issued in the corresponding French and PCT applications Nos. 9805197 and PCT/FR00974.
Giovannangeli et al, Accessibility of nuclear DNA to triplex-forming oligonucleotides: The integrated HIV-1 provirus as a target. Proceedings National Academy of Science, U.S.A., Jan. 1997, vol. 94, pp. 79-84.
Batra et al., Transduction of Non-Small Cell Lung Cancer Cells by Adenoviral and Retroviral Vectors, Am. J. Respir. Cell Mol. Biol., (1998) 18:402-410.
Blomer, U., et al., Abstract In-vitro and In-vivo Study of Gene Transfer with a New HIV Derived Vector, Zentralbl Neurochir Supplement (1996).
Johnson et al., Effect of Host Modification and Age on Airway Epithelial Gene Transfer Mediated by a Murine Leukemia Virus-Derived Vector, Journal of Virology, (1998) 72(11):8861-8872.
Matukonis et al, “Development of Second- and Third-Generation Bovine Immunodeficiency Virus-Based Gene Transfer Systems,” Human Gene Therapy (2002) 13:1293-1303.
Molina et al.,“Mapping of Bovine Immunodeficiency Virus Packaging Signal and RRE and Incorporation into a Minimal Gene Transfer Vector,” Virology (2002) 304:10-23.
Negre, D., ETA/., “Characterization of Novel Safe Lentiviral Vectors Derived from Simian Immunodeficiency Virus (SIV mac251) that Efficiently Transduce Mature Human Dendritic Cells,” Gene Therapy (2000) 7:1613-1623.
Olsen, JC, “Gene transfer vectors derived from equine infectious anemia virus,” Gene Therapy (1998) 5:1481-1487.
Poeschla et al. “Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors,” Nature Medicine (1998) 4(3) 354-357.
Poeschla et al. “Identification of a Human Immunodeficiency Virus Type 2 (HIV-2) Encapsidation Determinant and Transduction of Nondividing Human Cells by HIV-2-Based Lentivirus Vectors,” Joumal of Virology (1998) 72(8) 6527-6536.
Sirven, “The human immunodeficiency virus type-1 central DNA Flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells,” Blood (2000) 92(13) 4103-4110.
Riggs et al., A Novel Human Amphotropic Packaging Cell Line: High Titer, Complement Resistance, and Improved Safety, Virology 218, 290-295 (1996).
Charneau Pierre
Firat Hüseyin
Zennou Veronique
Humphrey Louise
Institut Pasteur
Law Office of Salvatore Arrigo and Scott Lee, LLP
Lucas Zachariah
LandOfFree
Use of triplex structure DNA in transferring nucleotide... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of triplex structure DNA in transferring nucleotide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of triplex structure DNA in transferring nucleotide... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2717672